We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Rivian
RIVN
$24.3B
| $107K | ﹤0.01% |
7,762
+3,659
| +89% | +$49.6K |
|
1577
Eversource Energy
ES
$26.7B
| $106K | ﹤0.01% |
1,671
-10
| -0.6% | -$616 |
|
1578
Coca-Cola Europacific Partners
CCEP
$47.4B
| $103K | ﹤0.01% |
1,109
-38,732
| -97% | -$3.47M |
|
1579
Avery Dennison
AVY
$13.5B
| $102K | ﹤0.01% |
583
-628
| -52% | -$110K |
|
1580
Corpay
CPAY
$26.5B
| $102K | ﹤0.01% |
308
+297
| +2,700% | +$96.9K |
|
1581
PACCAR
PCAR
$66.6B
| $102K | ﹤0.01% |
1,071
-1,236
| -54% | -$114K |
|
1582
Cincinnati Financial
CINF
$26.5B
| $101K | ﹤0.01% |
+680
| New | +$97.4K |
|
|
VMRK
1583
Vivmark Residential
VMRK
$26.1B
| $100K | ﹤0.01% |
+1,488
| New | +$102K |
|
1584
Westlake Corp
WLK
$9.45B
| $99.2K | ﹤0.01% |
1,307
-1,862
| -59% | -$152K |
|
1585
Pliant Therapeutics
PLRX
$71.2M
| $99.1K | ﹤0.01% |
85,421
+26,212
| +44% | +$37K |
|
1586
Comstock Resources
CRK
$4.29B
| $98.1K | ﹤0.01% |
+3,546
| New | +$80.7K |
|
1587
Kraft Heinz
KHC
$29.8B
| $97.1K | ﹤0.01% |
3,760
-1,715
| -31% | -$47.6K |
|
1588
Labcorp
LH
$27.3B
| $95.6K | ﹤0.01% |
364
-462
| -56% | -$112K |
|
1589
Aptiv
APTV
$9.43B
| $95K | ﹤0.01% |
1,392
-485
| -26% | -$30K |
|
1590
CMS Energy
CMS
$21.4B
| $91.2K | ﹤0.01% |
1,317
-11
| -0.8% | -$784 |
|
1591
Waters Corp
WAT
$41.4B
| $90.4K | ﹤0.01% |
259
-1,294
| -83% | -$445K |
|
1592
Insperity
NSP
$1.98B
| $89.8K | ﹤0.01% |
1,493
-3,716
| -71% | -$260K |
|
1593
Fox Class B
FOX
$25.4B
| $86.2K | ﹤0.01% |
1,670
+1,090
| +188% | +$53.1K |
|
1594
Keurig Dr Pepper
KDP
$43.4B
| $85.8K | ﹤0.01% |
2,595
+502
| +24% | +$17K |
|
|
CTRA
1595
DELISTED
Coterra Energy
CTRA
| $84.3K | ﹤0.01% |
3,321
+85
| +3% | +$2.15K |
|
1596
McCormick & Company Non-Voting
MKC
$14.7B
| $83.4K | ﹤0.01% |
1,100
-10
| -0.9% | -$749 |
|
1597
Invitation Homes
INVH
$17.4B
| $81.4K | ﹤0.01% |
+2,481
| New | +$83.3K |
|
1598
Southwest Airlines
LUV
$19.5B
| $80.5K | ﹤0.01% |
+2,480
| New | +$74.7K |
|
|
DVAX
1599
DELISTED
Dynavax Technologies
DVAX
| $79.4K | ﹤0.01% |
8,000
| – | – |
|
1600
Ross Stores
ROST
$73.7B
| $79.1K | ﹤0.01% |
620
-56,755
| -99% | -$7.88M |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.